A study comparing conventional chemotherapy to low dose total body irradiation-based
conditioning and hematopoietic cell transplantation from related and unrelated donors as
consolidation therapy for older Patients with AML in first Complete Remission.
Phase:
Phase 3
Details
Lead Sponsor:
Clinical Trials European Society for Blood and Marrow Transplantation
Collaborators:
Acute Leukemia French Association East German Study Group of Hematology and Oncology (OSHO) European Organisation for Research and Treatment of Cancer - EORTC French Innovative Leukemia Organisation Grupo Cooperativo de Estudio y Tratamiento de las Leucemias Agudas y Mielodisplasias HOVON - Dutch Haemato-Oncology Association Swiss Group for Clinical Cancer Research